DIFFERENTIAL METHYLATION AS A BIOMARKER OF RESPONSE TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Plant, D. [1 ]
Webster, A. [2 ]
Nair, N. [2 ]
Oliver, J. [2 ]
Smith, S. [2 ]
Eyre, S. [2 ]
Hyrich, K. L. [2 ]
Wilson, A. G. [3 ]
Morgan, A. W. [4 ,5 ]
Isaacs, J. [6 ,7 ]
Worthington, J. [1 ,2 ]
Barton, A. [1 ,2 ]
机构：
[1] Manchester Acad Hlth Sci, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England
[2] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England
[3] Univ Coll Dublin, UCD Sch Med & Med Sci, Conway Inst, Dublin, Ireland
[4] Univ Leeds, Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[6] Newcastle Univ, NIHR Newcastle Biomed Res Ctr Ageing & Chron Dis, Newcastle Upon Tyne, Tyne & Wear, England
[7] Newcastle Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-209124.156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A8.03
引用
收藏
页码：A66 / A66
页数：1
相关论文
共 50 条
  • [31] Etanercept in rheumatoid arthritis
    Cook, DA
    Dimick, JB
    Gallagher, DC
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25): : 2000 - 2000
  • [32] Rapid Remission in Response to Etanercept Therapy Results in Better Outcome in Patients with Rheumatoid Arthritis
    Raffeiner, Bernd
    Botsios, Costantino
    Ometto, Francesca
    Bernardi, Livio
    Vezzari, Cristiana
    Todesco, Silvano
    Sfriso, Paolo
    Punzi, Leonardo
    CLINICAL DRUG INVESTIGATION, 2013, 33 : S120 - S122
  • [33] Interleukin-6 promoter haplotypes are associated with etanercept response in patients with rheumatoid arthritis
    Heiko Schotte
    Hartmut Schmidt
    Markus Gaubitz
    Susanne Drynda
    Jörn Kekow
    Peter Willeke
    Bernhard Schlüter
    Clinical Rheumatology, 2015, 34 : 2021 - 2028
  • [34] PREDICTING RESPONSE TO ETANERCEPT IN RHEUMATOID ARTHRITIS PATIENTS USING WHOLE GENOME EXPRESSION PROFILING
    Smith, Samantha L.
    Plant, Darren
    Eyre, Stephen
    Hyrich, Kimme
    Morgan, Ann W.
    Wilson, A. G.
    Isaacs, John
    Barton, Anne
    RHEUMATOLOGY, 2014, 53 : 159 - 159
  • [35] Interleukin-6 promoter haplotypes are associated with etanercept response in patients with rheumatoid arthritis
    Schotte, Heiko
    Schmidt, Hartmut
    Gaubitz, Markus
    Drynda, Susanne
    Kekow, Joern
    Willeke, Peter
    Schlueter, Bernhard
    CLINICAL RHEUMATOLOGY, 2015, 34 (12) : 2021 - 2028
  • [36] Etanercept in Monotherapie or combined with Methotrexat in Patients with rheumatoid Arthritis
    Gaubitz, M.
    Krause, A.
    Lendl, U.
    Luethke, K.
    Lippe, R.
    Meng, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 112 - 112
  • [37] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
    Bathon, JM
    Martin, RW
    Fleischmann, RM
    Tesser, JR
    Schiff, MH
    Keystone, EC
    Genovese, MC
    Wasko, MC
    Moreland, LW
    Weaver, AL
    Markenson, J
    Finck, BK
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22): : 1586 - 1593
  • [38] Comparative pharmacokinetics of etanercept in patients with psoriasis or rheumatoid arthritis
    Nestorov, I
    DeVries, T
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P147 - P147
  • [39] Enbrel® (etanercept) pharmacokinetics in patients with rheumatoid arthritis.
    Kremer, JM
    Spencer-Green, GT
    Hanna, RK
    Korth-Bradley, JM
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S229 - S229
  • [40] HARNESSING QUANTITATIVE PROTEOMICS TO IDENTIFY BIOMARKERS OF TREATMENT RESPONSE TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ling, Stephanie F.
    Yap, Chuan Fu
    Nair, Nisha
    Bluett, James
    Morgan, Ann W.
    Isaacs, John D.
    Wilson, Anthony G.
    Hyrich, Kimme L.
    Barton, Anne
    Plant, Darren
    RHEUMATOLOGY, 2023, 62
12345